- The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01400-0 75 comments science
Linked pages
- Welcome to Python.org https://python.org 604 comments
- Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine | The Journal of Infectious Diseases | Oxford Academic https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216?searchresult=1 236 comments
- Creative Commons — Attribution 4.0 International — CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ 95 comments
- R: The R Project for Statistical Computing http://www.r-project.org/ 88 comments
- Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Nature Medicine https://doi.org/10.1038/s41591-021-01488-2 16 comments
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203965 15 comments
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2115481?query=featured_home 14 comments
- https://www.science.org/doi/10.1126/scitranslmed.abm2311 3 comments
- https://www.science.org/doi/10.1126/science.abl6184 3 comments
- https://www.science.org/doi/10.1126/scitranslmed.abm7853 0 comments
Related searches:
Search whole site: site:www.cell.com
Search title: BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age: Cell Reports
See how to search.